Physician profile
Latisha Johnson
NPI 1730704032
$672.90
in general payments reported to CMS, 2019-2025
11 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.41 · 2023: $105 · 2024: $162 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $257.00 | 2025 | Rapiblyk |
| Pfizer INC. | $151.10 | 2021-2024 | |
| Amgen INC. | $66.10 | 2021-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $38.20 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $35.43 | 2024 | Xarelto |
| Edwards Lifesciences Corporation | $26.49 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $22.97 | 2025 | Farxiga |
| Chiesi USA, INC. | $22.79 | 2024 | Cleviprex, Kengreal |
| Novo Nordisk INC | $22.19 | 2025 | Ozempic |
| Hologic Sales and Service, LLC | $17.09 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latisha Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.